Viewing Study NCT07002320


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-15 @ 3:19 AM
Study NCT ID: NCT07002320
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
Sponsor: Institute of Cancer Research, United Kingdom
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castrate-Resistant Prostate Cancer (mCRPC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate cancer View